3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Vomiting
1
Neoplasms
1
Nausea
1
Breast Neoplasms
1
Interventions
Dexamethasone
21
Palonosetron
16
Aprepitant
14
Ondansetron
12
Calcium Dobesilate
11
Granisetron
7
fosaprepitant
6
dexamethasone acetate
5
Doxorubicin
4
netupitant, palosentron drug combination
3
dexamethasone 21-phosphate
3
Olanzapine
3
Diphenhydramine
3
Cyclophosphamide
3
Cisplatin
3
netupitant
2
Vincristine
2
Therapeutics
2
Surveys and Questionnaires
2
Sugars
2
Radiotherapy
2
Metoclopramide
2
Mesna
2
Lorazepam
2
Ifosfamide
2
Fluorouracil
2
Dronabinol
2
rolapitant
1
phenazine
1
ginger extract
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Vomiting
×
alizapride
×
Clear all
NCT01636947
2018-09-25
KMEC
Merck Sharp & Dohme LLC
Phase 4
Completed
494 enrolled
14 charts